Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Fortacin™ Receives Extremely Encouraging Assessment in US Market Research Analysis 2021-07-28 20:05
I-Mab Announces IND Acceptance for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China 2021-07-28 19:15
Eccogene Announces Completed First-in-human of ECC0509 in Phase 1a Clinical Trial in Australia 2021-07-28 17:13
Kintor Pharmaceutical Announces Dosing of First Batch of Subjects in Phase I Clinical Trial of GT20029 in China 2021-07-28 13:47
India-based MedTel receives investment term sheet from Catalist-listed Metal Component Engineering (MCE, SGX:5DX) 2021-07-28 11:36
More than Half of Singaporeans Unaware of Link between Viral Hepatitis and Liver Failure: Survey 2021-07-28 11:00
Gilead Sciences Announces Launch of Asia Pacific ALL4LIVER Grant 2021 2021-07-28 11:00
Ascletis Announces Completion of 149 Patient Enrollment and Positive Interim Results of Phase IIb Chronic Hepatitis B Study in China for its Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) 2021-07-28 08:30
I-Mab Announces Preliminary Proposal for Potential Dual Listing on the STAR Market of the Shanghai Stock Exchange 2021-07-27 20:35
VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant 2021-07-27 19:53
PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference 2021-07-26 20:00
HBM Presents Phase I Data on Next-Generation Anti-CTLA-4 Antibody at ESMO Congress 2021 2021-07-26 19:11
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility 2021-07-26 18:00
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors 2021-07-26 08:00
GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices 2021-07-23 21:02
Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand 2021-07-23 16:00
FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical Trials Of CoviDTH 2021-07-22 21:50
Intas Enters into an Exclusive License Agreement with Meiji and Dong-A ST to commercialize DMB-3115 (Proposed Biosimilar to Ustekinumab) 2021-07-22 13:00
Antengene Announces The Approval by Human Research Ethics Committee in Australia and to Start the Phase 1 Trial of ATG-101 (the first PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma 2021-07-22 09:27
Joysbio's COVID-19 RAPID tests detect NEW SARS-COV-2 variants 2021-07-22 08:37
1 233 234 235 236 237 413